KMPlotter analysis of NEK10 expression reveals positive patient survival correlations with breast cancer, kidney renal papillary carcinoma, pancreatic ductal carcinoma, thymoma, and uterine corpus endometrial carcinoma (HR < 1, p-value < 0.05) and negative correlations with survival in kidney renal cell carcinoma, stomach adenocarcinoma, and thyroid carcinoma (HR > 1, p-value < 0.05) (Table 1). Here, NEK10 is linked to breast cancer.